Harry Harris was bom on 30 September 1919. He was one of the most influential scientists in the field of human genetics during the postwar period in Britain up to 1976, and after that in the United States until his death in July 1994. With his extensive laboratory research on the patterns of human genetic diversity in health and disease, Harris became the acknowledged world leader in human biochemical genetics and assumed the mantle of Archibald Garrod, the founding father. He demonstrated in a series of experiments commenced in 1960, that genetic variation in man (and by implication, other species) was not something rare and unusual and was not always associated with disease. Variation was shown to be commonplace and usually harmless. Harris was also the first to draw attention to the fact that we are all individually different in our genetic constitution and, using simple biochemical tests on isozymes, was able to demonstrate that no two individuals except for identical twins are exactly alike in their genetic make-up. This work prepared the ground for many of the current well known genetic concepts and applied procedures, such as the identification of individuals by DNA 'fingerprints' and prenatal diagnosis of genetic disorders. It also led directly to mapping human genes on chromosomes and to the demonstration of considerable allelic heterogeneity in inherited disease. He wrote extensively about his work in research papers and reviews and a series of very influential books (see accompanying Bibliography on microfiche). His first book was An Introduction to Human Biochemical Genetics in 1953 and his last the enlarged 3rd edition of his Principles o f Human Biochemical Genetics in 1980. He delivered more than 20 named lectures (see accompanying Bibliography on microfiche) and some of these were also published.
Most of his career in the U.K. was centred in London. Following appointments in genetics and in biochemistry at University College, London, and at the London Hospital Medical College, Harris served as Professor and Head of the Department of Biochemistry at King's College, London, from 1960 -65. In 1961 Harry Harris had an outstanding career which was devoted to science but sadly shortened by chronic diabetes and he had only a brief glimpse of retirement.
E a rly y e a r s
Harris came from a family of Eastern European Jewish immigrants. He was born in Manchester on 30 September 1919, the eldest son of Sol David Harris, a small-scale garment manufacturer, and Sarah Harris (nee Chazan), whose father was a religious bookseller. Harris went to the Grecian Street Elementary School in Salford and then to Manchester Grammar School, where his interests and abilities in science were strongly encouraged. Professor Sir James Baddiley, F.R.S., knew him well at school and provided the following commentary:
We both spent two years in the same division of the science sixth form at Manchester Grammar School. The sixth form at M.G.S. was large even in those days and comprised a number of divisions according to subject combinations. Our combination was chemistry, physics and biology. Most boys studying that combination went on to read medicine at university. Harry was a very bright boy, the top of his class. This was no mean feat, as the school contained many very able boys. Contemporary with us was R.E. Davies (later F.R.S.) in a related division and coming along a year or two later was G.W. Kenner (later F.R.S.). M. Atiyah (later P.R.S.), W. Bodmer (later F.R.S.) and J.C. Polanyi (later F.R.S. and Nobel Prize) were to follow within a few years.
Harry was a friendly boy, much liked by his classmates, with an excellent sense of humour. Like most of us, he worked hard but appeared to take everything in his stride and was certainly no recluse. I don't think he was particularly interested in sport, but was always very good company socially. Science teaching at M.G.S. in those days was good and I am sure that, like myself, Harry was especially inspired by the teaching of biology by W.B. Yapp. We covered much more than the Higher School Certificate syllabus and this extended from natural history and environmental biology through anatomy, physiology and biochemistry.
I have the impression that Harry's parents were orthodox Jews but at that time he was not. I did not ask him later in life whether he had modified his view of religion but at school he appeared to be at least agnostic. Genetics was very much a minority interest at that time and a career move in this direction was very unusual for a newly qualified doctor. Harris discussed his reasons with the author Daniel Kevles when the latter was researching background for his book In the Name o f Eugenics (1995) . Briefly, the literature in the current medical journals on the emerging complexity of the genetics of the human blood groups (in particular RH, or Rhesus as it was known then) was one factor; premature baldness in his father and all the uncles on his father's side of the family was another; and J.B.S. Haldane's New Paths in Genetics (1941) was the third and probably the most crucial factor which drew Harris towards a career in human genetics. Harris described it as a 'beautiful book' in his talks with Kevles and also acknowledged his sympathy with Haldane's political stance, well to the left.
Harris won an
Relatively under-occupied with the routine duties of providing health care for the extremely fit young men of the R.A.F., Harris conceived a large-scale study of the inheritance of premature baldness. He surveyed a consecutive series of more than 900 service men, aged between 30 and 42, and recorded a history and age of onset of baldness in their immediate relatives (1)*. The study was a model of thoroughness, imaginative hypothesis and rigorous statistical evaluation and later (in 1949) formed the basis for his M.D. thesis. Harris sent it off to the Annals o f Eugenics, a journal which he had discovered by chance at the B.M.A. library in London whilst on a day's leave, and he was delighted to receive a 'sweet note' of acceptance from Lionel Penrose telling him that it would be published (Kevles 1995). Harris's career in human genetics was launched and he joined the Galton Laboratory after being demobilized from the R.A.F. Soon afterwards in 1948, he married Muriel (Hargest), who was his constant life-long support both at home and in his travels abroad. They had one son, Toby, who started off studying natural sciences at Cambridge like his father, but ended reading politics and economics and displayed the strong left-wing passion for social justice of his mother and father.
In the final phase of his wartime service Harris conducted a study of the relationship between baldness and the growth of hair over the rest of the body (2). This remarkable survey, involving hundreds of men and dozens of notebooks to record the data, reached a peak in the final phase of demobilization of airmen after the war. Harris as a presiding M.O. sat in the centre of a long Nissen hut. The men entered at one end, fully kitted out, and passed down the hut in line gradually shedding gear, until totally naked they reached Harris ready to be certified as fit for discharge. No doubt to their astonishment Harris assessed their baldness, asked about their family history, scored their body hair arbitrarily on a scale of 1 to 4 in different regions of the body, before passing the bemused squaddies as 'fit' irrespective of their hairiness but provided they were free of scabies and lice. It was an early example of Harris at his most inventive, his insatiable curiosity and his ability to handle large amounts of data from an unlikely source. There was no money available for a formal job when Harris joined the Galton Laboratory, but at the suggestion of Penrose, a Leverhulme Research Scholarship from the Royal College of Physicians was obtained for him to work on the genetic aspects of diabetes for the next two years. In 1949 he was supported for a further year on a Lund Research Fellowship from the British Diabetic Association. Harris was soon at work on a massive survey of the familial distribution of diabetes mellitus in more than a thousand individual diabetics attending Dr R.D. Lawrence's clinic at Kings College Hospital, Denmark Hill. This was an immensely thorough undertaking and the papers which emerged (3-5, 9, 12,13) comprised a landmark study of a complex genetic disorder. Harris derived great satisfaction from his work on diabetes and was always pleased when it was cited, as it continued to be right up to the time of very recent work, which has led to the definition of the major loci involved (Todd 1995). However, Harris must have found it strange and somewhat galling a few years after having completed his research to become a severe diabetic himself and to attend the same clinic at Denmark Hill.
From the very beginning of his period at the Galton, Harris was encouraged to explore outside the range of his funded work on diabetes. There were numerous opportunities and under the guidance of Penrose, Harris was attracted to topics that could be analysed using objective criteria in families and in large-scale population surveys. He was greatly influenced by Haldane's account in New Paths in Genetics (1941) and by the foundations of modem biochemical genetics being laid by Beadle and Tatum and their development of the one-geneone-enzyme hypothesis. He also turned to Garrod's much earlier work on the human inborn errors of metabolism and considered the use of chemical tests to study genetic variation in human health and disease. His work with Kalmus on the PTC (phenyl-thio-carbamide) taste polymorphism and collaboration with Dent on the detection of normal variation in urinary amino acid composition arose directly from this background and crucially shaped the pattern of Harris's research for the rest of his life.
The PTC polymorphism had been discovered by chance in a chemical factory in the 1930s. It was fairly easily recognized as an apparently dominant condition with two phenotypes, tasters and non-tasters, the latter assumed to be homozygous for a recessive allele. The early testing methods were however not totally reliable or reproducible, as there were too many opportunities for vague subjective impressions to influence the subjects and the observers. Harris and Kalmus carried out a critical and exhaustive analysis of the taste test system and came up with a very simple new procedure, which is still the standard method for this type of investigation (6). A series of PTC solutions is prepared by doubling dilution. The subject determines an approximate threshold by tasting the standard solutions, starting at the low end and stopping when first discerning the taste. A set of eight beakers is then prepared, four with PTC at the provisional threshold concentration and four with water. These are then given to the subject as a blind test with the instruction that they ought to be able to separate the beakers into two groups of four which are with and without taste. If the subject is successful the test is repeated, with the next lowest concentration and so on until the ability to discriminate is lost. The last correct answer is taken as the threshold. If the subject has difficulty in separating the two groups of beakers the test is repeated, at the next highest concentration and so on until accurate classification is achieved. Harris and Kalmus were also able to extend considerably the range of compounds in their tests and showed that =N-C=S is the vital chemical group responsible for the bimodality of taste and that many of the compounds are goitrogenic (7, 8, 14, 15) . In addition they carried out substantial population and family studies, for example using 384 sib pairs, to show that the genetical basis of the PTC polymorphism was probably more complex than a simple two allele system, which was the hypothesis at that time. This work was important in Harris's development for several reasons: it was an example of variation in normal healthy individuals; it echoed Garrod's dictum about commonly occurring person-to-person variation in metabolism and it also pointed up the connection between the specificity of chemical compounds and human genetic traits.
These themes continued when Harris 'left' the Galton Lab in 1950 and crossed the quadrangle to join the U.C.L. Department of Biochemistry. The move signalled the end of his Lund Fellowship on diabetes research and the start of a salaried position as a Lecturer in U.C.L. However, all of Harris's papers for the next three years show the Galton Laboratory as his address. This signified the continued influence of Penrose and his colleagues and the excellent resources at the Galton for the collection and cataloguing of family material. The most important feature of the transfer to the Biochemistry Department was that Harris now had facilities to carry out 'proper biochemistry'. The Galton Lab was not well equipped in this respect and Harris was becoming enthusiastic about the new separation methods of chromatography and electrophoresis that were beginning to be introduced for the investigation of clinical case material. Charles Dent, for example, a physician in U.C.H., was using paper chromatography to investigate his patients with renal disorders. Dent taught Harris how to perform paper chromatography and their first project was to investigate the occurrence and identity of a completely unknown amino acid which Dent had found in the urine of normal healthy individuals. The substance was shown to be 6-amino-isobutyric acid (10) and its occurrence appeared to be genetically determined (19, 25) . Dent then invited Harris to investigate the patterns of urinary amino acid excretion in his patients with cystinuria, one of the conditions on Garrod's original list of inborn errors. This led to a major series of publications and the elucidation of genetic heterogeneity in the condition (11, 16, 17, 20, 24, (27) (28) (29) 31) . The loss of cystine in the urine was shown to be associated with low to normal plasma cystine levels, suggesting that the underlying lesions were in excretion rather than metabolism of the amino acid. In related studies Harris went on to distinguish two forms of the Fanconi Syndrome, discovered Hartnup Disease and cystathioninuria and regularly compiled major reviews of the genetic aspects of renal disease. It is also interesting to note how quickly he spread these simple chromatographic methods to other topics such as the comparative analysis of urinary amino acid patterns in inbred strains of mice (18) and large mammals at the London Zoo (21) as well as pyridoxine deficiency in rats (22, 23) . This facility to run several different projects simultaneously was to become a distinctive characteristic.
By now Harris had produced almost 40 papers based largely on his own research efforts into the genetics of diabetes, tasting and aminoaciduria. Encouraged by Penrose, he was also about to demonstrate his considerable talent at simplifying the complex subject of human biochemical genetics for a broad audience. By the time he left U.C.L. in 1953 to become Senior Lecturer in Biochemistry at the London Hospital Medical College he had already produced his first assessment of the subject in An Introduction to Human Biochemical Genetics, published for the Galton Laboratory by Cambridge University Press. This 90-page effort was remarkably forward-looking with a section on multiple allelism and a detailed discussion of genetic heterogeneity in apparently simple characters, topics which are now firmly embedded in medical genetic thinking but at that time were less than rudimentary. Harris conveys a tremendous sense of purpose and knowledge in this short treatise despite the fairly scanty information available to him at that time. For example, the precise metabolic basis (viz. the enzyme defect)
had not yet been directly demonstrated for any of the inborn errors and the number of genes involved in haemoglobin synthesis was still a mystery. His monograph was a major stimulus to studies in human biochemical genetics all over the world. For instance, there were numerous North American visitors, scientists and medical doctors, on sabbatical leave at the Galton Laboratory in those days and Harris was beginning to acquire a substantial following in the United States. This surely influenced him 20 years later when he decided to move to Philadelphia in 1976.
Harris formed a close friendship with F.L. (Willie) Warren in the biochemistry department at U.C.L. Figure 1 shows a typical scene from those days with Warren, having dispensed sherry into 250-ml beakers, toasting their successful exploits in the lab. Harris, characteristically smiling, smoking a pipe and wearing a bow tie, stands on one side and E.M. (Eric) Crook stretches his foot near the camera. One person missing from this picture is S.P. (Prakash) Datta, another good friend of those days and very much involved with their early experiments with chromatography and electrophoresis. Warren was a wizard with the polarograph, a tricky instrument in those days but invaluable for the quantitation of cystine in the cystinuric patients and their families. When Warren was offered the newly established Chair of Biochemistry at the London Hospital Medical College, it was natural for him to invite Harris to join him there and help in setting up the department. Several major strands of genetic research emerged from Harris's lab during this period. His research on human aminoaciduria and renal disorders was very significant, as recorded above, using paper chromatography together with polarography and rather neat microbiological methods, which Harris devised using mutant strains of Escherichia coli, to assay specific amino acids. This also spread to ionophoresis of amino acids and electrophoresis of proteins such as haemoglobin. In addition, Harris established a very productive collaboration with C.S. (Cecil) Cummings in the Department of Bacteriology in the London Hospital, developing a form of taxonomy based on the chemical composition of bacterial cell walls (26, 30, 33-36, 40, 41) . Their novel approach was to record strain differences in the chromatography patterns of the bacterial amino acids and amino sugars. The method was quick, low cost and easily applied to very large numbers of samples and gave unambiguous data, features which became the hallmarks of the Harris research method. Interesting basic data on the classification and evolution of different strains of gram-positive bacteria emerged, as well as information of practical value for example, in assessing whether strains identified in animal lesions might also be responsible for human pathology.
Harris was also very intrigued with genes and enzymes and in particular the ways in which variation in the one influenced the level of activity of the other. He was especially curious about heterozygous carriers of mutations responsible for the enzyme defects underlying classical inborn errors of metabolism and he puzzled endlessly about the factors which might determine the amount of enzyme synthesized, whether effects were observed or not in heterozygotes and whether dosage effects could be modified experimentally ( e.g. 32). The literature beginning to accumulate on what are now classical human pharmacogenetic polymorphisms was to prove helpful to this research. Thus Harris immediately embraced atypical cholinesterase (discovered as a result of an aberrant response to the anaesthetic agent succinyl choline) and glucose-6-phosphate dehydrogenase deficiency (an X-linked disorder discovered in black male U.S. soldiers receiving anti-malarials in preparation for the war in Korea) as topics for further study. For the research on cholinesterase Harris recruited a young post doc from the London Hospital (Mary Whittaker) who had had first-hand experience of the effects of anti-cholinesterase drugs from her work as an industrial chemist. They performed a huge range of analytical studies on the cholinesterases, focusing on kinetic profiles and inhibition characteristics, including studies of the effects of naturally occurring compounds such as solanines in potatoes (39, 42^46, 49) . This led directly to a clearer understanding of the relationships between genes and enzymes, with the discovery of numerous alleles at significant frequency in the general population and the identification of multiple loci. Furthermore, this basic work on the cholinesterases set the stage for the most significant phase of Harris's research career, which involved the analysis of enzymes and their isozymes by electrophoresis, as the first isozyme experiments were done on serum cholinesterase (47).
The power of electrophoretic analysis for the detection and demonstration of genetic variation in human proteins had been obvious to Harris, and of course many others, since the early work of Pauling on sickle cell haemoglobin in 1949. But the resolution provided by the classical Tiselius apparatus and the primitive methods of zone electrophoresis were poor. The first major opportunity for systematic electrophoretic analysis of human proteins came in 1955 with the description of starch gel electrophoresis (Smithies 1955 (Smithies , 1996 . This new procedure combined the facility of separating proteins by size as well as charge and thus provided considerably enhanced resolution of complex mixtures. Harris was very quick to follow up Smithies' discovery of the human serum haptoglobin polymorphism and rapidly assembled population and family data on the new system and discovered several new phenotypes, including evidence for a null allele (37, 38). The first starch gels were tricky to make, because the procedure depended on the use of partially hydrolyzed starch. There was considerable batch variation in the efficacy of gel-making using the B. (1963) . By this time Harris was regarded as the international leader of human biochemical genetics and the successor to Garrod himself. When he moved to King's, his sights were firmly set on investigating the extent of genetic variation in healthy human individuals using population and family studies and simple screening techniques such as gel electrophoresis. He wanted to explore the interface between normal and pathological variation. He was driven by the vision of 'chemical individuality' conjured up by Garrod (1902) in his classical study of the inborn error alkaptonuria: 'just as no two individuals of a species are absolutely identical in bodily structure neither are their chemical processes carried out on exactly the same lines'.
Harris recognized that he had the technological power to illuminate this concept. He therefore set about raising funds for this major project from the Medical Research Council to form a new unit concerned with human biochemical genetics. This unit was established at King's College, London, with Harris as the Honorary Director in January 1962, and moved with him to the Galton Laboratory.
The pace of discovery was astonishing. Only three years later, in March 1965, Harris was able to present a major review of enzyme polymorphisms in man at a meeting in London convened by the Royal Society and the Genetical Society of Great Britain to commemorate the Centenary of Gregor M endel's papers on experiments in plant hybridization (50). He was able to describe three new enzyme polymorphisms (acid phosphatase, A C PI, phosphoglucomutase, PGM1, and adenylate kinase, AK1), which were discernible by starch gel electrophoresis from amongst a series of ten arbitrarily chosen enzymes. Remarkably this estimate of the overall incidence of genetic polymorphism in coding sequences, 1 in 3 loci, is exactly in line with present day estimates. Furthermore, he was able to assemble data on the genetically determined biochemical individuality of the English population which showed that the commonest combination of enzyme phenotypes known at that time would occur in less than 4 per cent of the population and the probability that two people selected at random would have the same combination of phenotypes was less than 1 in 70. The report was not restricted to electrophoretic screening in families and populations but also provided detailed descriptions of the biochemical properties of the various isozymes and their patterns of expression in different tissues. Thus it was concluded, correctly, that red cell acid phosphatase is encoded by a different locus from other acid phosphatases. Also, electrophoretic polymorphism was often shown to be associated with small but significant differences in enzyme activity. Harris was quick to grasp the significance of this simple connection between qualitative and quantitative variation and its application to the analysis of complex 'polygenic' disorders. His illustration (figure 2) of the distribution of the red cell acid phosphatase activity associated with different phenotypes, taken from his Mendel symposium lecture and published in the Proceedings o f the Royal Society (50), became a classic illustration in medical and statistical text books worldwide. The continuous bell-shaped overall distribution of activity actually represents a 'summation of a series of separate but overlapping distributions corresponding to each of the qualitatively different phenotypes'. There was enormous excitement at the occasion of the Mendel symposium, not only in the contribution from Harris and others on 'Genetics of Man', but also in the very much wider sense of advances relating to the genetic code, transcription, microbial genetics, chromosome structure and even an appraisal of non-Mendelian heredity. However, not every one was satisfied and I vividly recall one senior British geneticist grumpily exclaiming to his post docs during a coffee break that it was: 'Absolutely typical. Smithies (a speaker in the same session as H arris)... all speculation and no fact. Harris all fact and no speculation'! Similar facts did actually emerge on the other side of the Atlantic in Richard Lewontin's laboratory at Harvard, where the level of genetic polymorphism in Drosophila melanogaster was also being exposed, quite independently, by isozyme analysis (Lewontin and Hubby 1966) . Remarkably the incidence of polymorphism and the level of heterozygosity in Drosophila were very similar to those recorded in man. A new era in population genetics, concerned with the relative significance of natural selection versus random genetic drift in maintaining isozyme polymorphisms had dawned. During the next 10 to 15 years Harris contributed enormously to this debate by providing huge amounts of objective data on human genetic variation and cool dispassionate analysis in the middle ground between the extreme selectionist and the neutralist views (52, 54, 57, (59) (60) (61) (62) (63) (64) (65) (66) (67) 72) . , 1965-76 Harris was appointed to succeed Penrose in the Galton Chair well in advance of the latter's retirement. This was to allow Harris to be involved in the planning and laboratory design of a new six-floor building dedicated to genetics at U.C.L. The building was formally opened by Isaac Wolf son in May 1967. The famous benefactor revealed that he had only two speeches: one when he was asked for money, the other (used on this day) when he had given it. The press was in attendance and The Times exposed the concept of genetic polymorphism to the general public under the neat headline 'We are what our genes make us'.
Harris expanded his team substantially to fill the new space and the next ten years were extremely productive. Each new recruit took on a different enzyme as a topic for research and starch gels became general purpose tools, which were used not only for the separation of the isozymes but for the investigation of their biochemical properties. Obvious characteristics such as substrate specificity and inhibition properties could be determined by simple modification of the in situ isozyme staining mixtures (e.g. 51). However, the procedures became more and more sophisticated with the in situ investigations of thermal stability (e.g. 58), subunit structure (e.g. 55), sulphydryl group reactivity (e.g 56) and so on until a complete dossier was compiled on each locus or gene family. In several instances very detailed predictions could be made about the nature of the structural differences among the isozymes and in some cases the precise nature of the amino acid substitutions, and in this way the DNA base changes underlying a polymorphism were deduced (e.g. 53). Things were organized so there was an enormous wealth of material available for analysis, with large amounts of family material coming almost on a routine daily basis from the M.R.C. Units in Edinburgh (Population and Cytogenetics) and the Lister Institute in London (Human Blood Group Unit) and from a wide range of clinicians. Population samples came regularly from the Blood Transfusion Centre via Tom Cleghorn, who was the Unit's honorary serologist. Blood and placenta samples came from newborn twins in Oxford, Birmingham and Aberdeen as part of zygosity studies and these were supplemented with a very large twin survey on samples from Nigeria, where the dyzygotic twin rates were among the highest in the world. Post mortem specimens from a very wide range of age groups were also obtained on a routine basis and Harris even engineered the employment of a part-time ex-nurse to collect these tissues from pathologists in Oxford on a daily basis, flash freeze them and bring them to London every week.
More than 30 new enzyme polymorphisms were identified and a picture of the range of genetic variability across more than a hundred gene loci was obtained. Polymorphism was shown to be a universal phenomenon and the majority of human enzymes found to be determined by more than one locus. These ideas are now commonplace and are underpinned with data gathered directly from molecular analysis of the genes themselves but at the time they were revolutionary. Harris played a major role as missionary in converting the medical establishment to understand the consequences of the widespread occurrence of multiple allelism and multiple loci. For example, it flows from the former that most patients with classical recessive disorders and no history of consanguinity are much more likely to be heterozygous for two different defective alleles than homozygous for one, and the combination of alleles in each family is likely to be unique. The concept of common versus rare alleles was also defined and their contributions to human diversity and biochemical individuality established. In many instances the enzyme loci displayed a continuous series of alleles ranging from the frankly pathological, through the moderate to the totally harmless.
While Harris presided over a massively productive laboratory during this period, he also continued a local Galton tradition of giving lectures in human genetics. These were attended by undergraduate and graduate students as well as more senior research workers. Harris was never really relaxed as a lecturer, his reliance on a prepared script probably reflecting the formal style of his own student days, but the courses were a great success and led to his third and most successful book The Principles o f Human Biochemical Genetics, published by North-Holland Press in 1970. This was a runaway best seller and was produced in Italian, German and Russian as well as English, even in the first edition. The second, completely revised, edition was distinguished by a Chinese version too and finally this classic text ended gracefully with a third edition in 1980, at a time when biochemical (viz. protein) genetics was being overtaken by molecular (viz. DNA) genetics. Between 1970 and 1980 Harris produced two other major books: one was a very early attempt to inform medical and lay opinion about the ethical issues beginning to emerge in human genetics with the increased knowledge of genetic disorders and the ability to perform prenatal diagnosis of several inherited diseases. The other book, on which I had the great pleasure of being coauthor, was a comprehensive dossier on enzyme electrophoresis, and became the standard handbook for isozyme analysis in many species, including plants, animals and parasites. At the time it had a unique format as a loose leaf publication so that updates could be published and slipped into place and local data easily inserted so that the book could be customized very easily. It was in fact the precursor of the laboratory manuals in molecular biology, which soon became very popular.
Harris enjoyed writing and was clearly very good at it, though he did not ever admit that it was a pleasurable activity. His writing 'method' depended on getting to grips with the fine detail of a subject before rendering the information into a crystal clear form. I was very struck by his fine level background research when attending an international meeting in London in the early seventies. Harris was discussing the biochemical genetics of the lysosomal enzyme hexosaminidase with Konrad Sandhoff during an interlude. The two of them were at it hammer and tongs over the precise ways in which the enzyme defect might lead to Tay-Sachs disease on the one hand or Sandhoff's disease on the other and whether there were parallels in other lysosomal storage diseases. Harris was not the least bit bowed by the extensive laboratory and clinical expertise of his opponent in this subject or the fact that Sandhoff had discovered one of the syndromes and given it his name. Afterwards, I asked Harris how he could possibly be so knowledgeable in this specialist area; he just grinned, shrugged and explained that he was currently revising that section in his book! His standards were very high and I recall him receiving only one rejection slip in his entire life while submitting more than 300 manuscripts for consideration of publication to a very wide range of scientific journals. This came from the neurologist Lord Brain, the editor of the journal Brain. He wrote a polite but withering note along the following lines about a paper Harris and colleagues had submitted on the electrophoresis of proteins in human cerebrospinal fluid:
Dear Harris, This manuscript is too slight for publication in Brain, Yours sincerely, Brain
Harris was amazed and amused. The paper was subsequently published in a different journal (48), and forgotten but he remembered the adjectival slight and used it with mock severity in later years when correcting manuscripts from students and post docs.
In the laboratory Harris was excellent in the communication of ideas and information. He had a capacious memory and a superb retrieval system so that conversations were often interrupted by a quick rummage through a pile of reprints before a vital fact for the next phase in planning an experiment or building a hypothesis was flourished. He was particularly generous in his attention to the youngsters in a group of scientists and would often pick up their ideas and run them in front of more senior colleagues in a manner that was exhilarating and inspirational. He generated an almost conspiratorial air in small group discussions and somehow would convey the impression that no one else in the whole world had yet caught on to the particular line of work being proposed and inspire the participants to believe they were at the leading edge of research. He kept everyone on their toes by his attention to detail and refusal to accept unguarded first approximations. He often emerged from discussion of laboratory data knowing more about an experiment and with better recall of the detail than people directly involved. His assessment involved not only the record of the outcome but also the performance of equipment and whether there was room for improvement on the practical side of the study. This involvement with the technical aspects of the work was all the more remarkable since Harris did not have a deft pair of hands. Also, he was never particularly active in the laboratory itself or inclined to do-it-yourself in his domestic and recreational activities. U n iv e r s it y o f P e n n sy l v a n ia , P h il a d e l p h ia , By the mid-seventies, after ten years as Galton Professor and more than 15 years as Director of the M.R.C. Human Biochemical Genetics Unit, Harris decided to move to a new position as Hamwell Professor of Human Genetics at the University of Pennsylvania Medical School, Philadelphia. This created a stir in the genetics community in the U.K. Here was someone in the premier chair of human genetics, with a large, stable, well-funded research group, who was planning to move to the United States at the age of 57 to set up a laboratory from scratch and to compete for new grants from the N.I.H. and other agencies in a strange and foreign land. In fact it was exactly the kind of challenge that Harris relished. He had always enjoyed star billing in the scientific and medical communities of the United States and Canada (for example he received the prestigious Allen Award of the American Society of Human Genetics in 1968), and in some ways felt more at home there than in the U.K. establishment. He could see the way research council funding was going in the direction of applied versus basic research, which came to a head in the customer/contractor relationship proposed by the Rothschild Think Tank and the bureaucratic encroachment on his university life and freedom was becoming too intense. His son, Toby, had finished at university and, most important of all, his wife Muriel was very keen and strongly supported his move to the United States. Harris was also pleased to discover that over there he would be able to work beyond the normal English retiring age of 65 and indeed he went on until he was 71 when the diabetes made him stop.
Harris elected to start his new life by working on a family of genes encoding phosphatases of mainly unknown function but of significant genetical interest. One of them, placental alkaline phosphatase, was at that time the most polymorphic enzyme locus of any other known in man and exhibited a vast array of common as well as rare alleles. His idea was to employ the relatively new techniques of monoclonal antibody production to generate locus-specific and allele-specific reagents for the different phosphatases. He succeeded brilliantly and developed a wide range of ingenious general purpose procedures for the investigation of protein variation (68) (69) (70) (71) (73) (74) (75) (76) . A few years earlier these would have been taken up and applied around the world in the unremitting search for a clearer view of genetic variation in human populations in health and disease. In fact, this did not happen as all attention was now swinging towards the methods of molecular analysis which were being developed to provide a window on the variability of the DNA itself. Harris was quick to recognize the power of the restriction enzyme and the related methods and moved his own lab in that direction. His group successfully cloned placental alkaline phosphatase and established the molecular basis of this complex polymorphism (77). Several other members of the gene family were also characterised and their molecular phylogeny established with characteristic precision (78-82). From then on the originality of his approach was lost but in these final years Harris had the pleasure of discovering that many of his earlier predictions in human molecular genetics were now testable and more often than not were found to be true. This final phase of his life and general attitudes are very well illustrated in a personal letter he wrote to me in 1988: phosphatases, which you know about, they started on the genes themselves. They have now completed the structures of the LBK gene (Mitchell) and the intestinal gene (Paula) and the two papers are now in press in the JBC. Since Brian Knoll in Texas, who collaborated on the placental cDNA has now got the structure of the placental gene done (it will be in the same issue of JBC, we hope) and Jose Millan who now works in California has published the cDNA and the structure of the placental-like gene, the whole picture is beginning to emerge. It has many fascinating ramifications. Among other things the LBK gene turns out to be more than five times as big as the three other genes which are all about the same size. This is entirely due to the much bigger introns. The exons are about the same sizes in all of them, and the intron/exon junctions all occur in essentially the same places. With Moyra [Smith] leading the way the precise chromosomal locations have been mapped. The placental, placental-like and the intestinal genes are closely linked near the end of the long arm of chromosome 2, while the LBK gene is near the end of the short arm of chromosome 1. This all fits together very sweetly with my earlier ideas about the evolutionary relationships, which were largely based on our immunological studies done some years ago.
We are now concentrating on defining the mutations in different cases of hypophosphatasia. This is coming full circle as far as I am concerned, because I first worked on the genetics of hypophosphatasia in the 1950s at the London Hospital using the now forgotten technique of twodimensional chromatography for amino acids in urine. We have material from quite a number of cases to work on, and it is going to be exciting to see what transpires. The techniques one has to use for this are truly amazing, and I barely understand them. They involve getting cDNA out of fibroblasts, expanding it with a thing called the polymerase chain reaction, and then doing the sequences of the products after a few more manipulations. It is to me, mind boggling, but I suppose it will be old hat within another year (or perhaps a month!) or two.
But I am rapidly approaching the end of my rope. I reach the age of 70 in September of 1989 and will have to retire from the faculty in June 1990. It so happens my N.I.H. grant finishes at about the same time and the last thing I want to do is apply for another one. So I shall be closing my lab in about two years time. ... I am therefore moving gradually into a retirement mode and trying to work out the best way to occupy myself.
It is a bit like an old R.A.F. ditty about repatriation from the Far East which I remember from my old days in Burma just after the end of the war: This is my story, This is my song. I've been in this Air Force, Too bloody long. So roll on the NELSON, the RODNEY, RENOWN We can't have the HOOD 'cos the bastard's gone down.
Actually the retirement mode should not be very different from the way I comport myself now. I have a comfortable study at home with a good computer (a Compaq Portable 386) and a laserjet printer. ... The computer has become the toy of my second childhood ... I do word processing, spreadsheets, databases, diagrams and plots for papers etc. and spend a lot of time trying to learn new programs. The only trouble about learning new programs is one has to remember how to work them after not using them for a few weeks. However it is all good clean fun and I enjoy it.
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